Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years

Authors: Iversen P.; Tyrrell C.J.; Kaisary A.V.; Anderson J.B.; Baert L.; Tammela T.; Chamberlain M.; Carroll K.; Gotting-Smith K.; Blackledge G.R.P.

Source: Urology, Volume 51, Number 3, March 1998 , pp. 389-396(8)

Publisher: Elsevier

Language: English

Document Type: Short communication

DOI: http://dx.doi.org/10.1016/S0090-4295(98)00004-1

Affiliations: 1: aUniversity of Copenhagen, , Copenhagen, Denmark

Publication date: 1998-03-01

• In this: publication
• By this: publisher
• In this Subject: Urology
• By this author: Iversen P. ;  Tyrrell C.J. ;  Kaisary A.V. ;  Anderson J.B. ;  Baert L. ;  Tammela T. ;  Chamberlain M. ;  Carroll K. ;  Gotting-Smith K. ;  Blackledge G.R.P.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers